Stock 22UA BIONTECH SE
Add to a list
To use this feature you must be a member
Log inSign up

Other languages BioNTech SE BOERSE MUENCHEN

Equities

22UA

US09075V1026

Real-time BOERSE MUENCHEN
Other stock markets
 09:14:01 2024-06-03 EDT 		5-day change 1st Jan Change
92.4 EUR -0.27% Intraday chart for BioNTech SE +3.87% -2.62%
05-31 European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower MT
05-29 BioNTech, CEPI Expand Partnership for mRNA Vaccine Ecosystem in Africa MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower
Patents, Policies And Privacy: The Highs And Lows Of Technology In IP
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 17 May 2024)
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 1 June 2022)
BioNTech : Publication of the resolutions and system for the remuneration of Supervisory Board Members (resolution of the AGM on 22 June 2021)
BioNTech : Publication of the resolutions and system for the remuneration of the members of the management Board (resolution of the AGM on 17 May 2024)
BioNTech, CEPI Expand Partnership for mRNA Vaccine Ecosystem in Africa
BioNTech gets $145 mln funding for African vaccine plants
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
BioNTech and CEPI Expand Partnership to Strengthen Africa?s mRNA Vaccine Ecosystem
BioNTech wins up to $145 mln in CEPI support for African mRNA vaccine plants
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading
BioNTech Collaborating with MediLink to Develop More Potential Antibody-Drug Conjugate, Immunotherapy Treatments
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership
European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower
BIONTECH : Deutsche Bank remains Neutral
Health Care Up as Vaccine Makers Gain - Health Care Roundup
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNTX Stock
  4. 22UA Stock
  5. News BioNTech SE
  6. Other languages